Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Limei Poon

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
JCO Global Oncology|October 22, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, et al.
Leukemia & Lymphoma|July 21, 2023
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter studyEsther Wei Yin Chang, Valerie Shiwen Yang, Shin Yeu Ong, et al.
Leukemia|September 25, 2024
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trialCatherine Thieblemont, Yasmin H Karimi, Herve Ghesquieres, et al.
Nature Communications|March 8, 2024
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphomaMin Liu, Giorgio Bertolazzi, Shruti Sridhar, et al.
JCO Precision Oncology|July 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's LymphomaRui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Cancer Discovery|April 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in LymphomaMichal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
JCO Global Oncology|October 22, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, et al.
Leukemia & Lymphoma|July 21, 2023
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter studyEsther Wei Yin Chang, Valerie Shiwen Yang, Shin Yeu Ong, et al.
Leukemia|September 25, 2024
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trialCatherine Thieblemont, Yasmin H Karimi, Herve Ghesquieres, et al.
Nature Communications|March 8, 2024
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphomaMin Liu, Giorgio Bertolazzi, Shruti Sridhar, et al.
JCO Precision Oncology|July 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's LymphomaRui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Cancer Discovery|April 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in LymphomaMichal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, et al.
Pageof 2